Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 0.36 is in line with its 5-year average of 0.36, near the low end of its 5-year range (0.15–0.86).
7.46% above its 12-month average of 0.33.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.07.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 34 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T19:38:35.198Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
0.36
EARNINGS PER SHARE (EPS) AVG TTM
0.33
EARNINGS PER SHARE (EPS) AVG 3Y
0.27
EARNINGS PER SHARE (EPS) AVG 5Y
0.36
EARNINGS PER SHARE (EPS) AVG 10Y
0.41
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+7.46%
CURRENT VS 3Y AVG
+32.11%
CURRENT VS 5Y AVG
-0.92%
CURRENT VS 10Y AVG
-12.63%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Viemed Healthcare, Inc.
Market Cap
$354.72M
Earnings Per Share (EPS)
0.36
TTM Avg
0.33
3Y Avg
0.27
5Y Avg
0.36
Market Cap
$354.03M
Earnings Per Share (EPS)
-2.41
TTM Avg
-4.66
3Y Avg
-5.40
5Y Avg
-4.56
Market Cap
$354.37M
Earnings Per Share (EPS)
-0.25
TTM Avg
-0.22
3Y Avg
-0.27
5Y Avg
-0.28
Market Cap
$357.39M
Earnings Per Share (EPS)
-3.31
TTM Avg
-3.43
3Y Avg
-2.65
5Y Avg
-2.61
Market Cap
$351.39M
Earnings Per Share (EPS)
-0.99
TTM Avg
-1.39
3Y Avg
-1.39
5Y Avg
-0.93
Market Cap
$356.23M
Earnings Per Share (EPS)
-0.14
TTM Avg
-0.19
3Y Avg
-0.48
5Y Avg
-0.56
Market Cap
$350.33M
Earnings Per Share (EPS)
1.48
TTM Avg
1.49
3Y Avg
2.03
5Y Avg
3.82
Market Cap
$348.22M
Earnings Per Share (EPS)
-0.29
TTM Avg
-0.18
3Y Avg
-0.18
5Y Avg
-0.18
Market Cap
$360.40M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.30
3Y Avg
-1.38
5Y Avg
-1.95
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viemed Healthcare, Inc. (VMD) | $354.72M | 0.36 | 0.33 | 0.27 | 0.36 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $354.03M | -2.41 | -4.66 | -5.40 | -4.56 |
| Ocugen, Inc. (OCGN)vs › | $354.37M | -0.25 | -0.22 | -0.27 | -0.28 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $357.39M | -3.31 | -3.43 | -2.65 | -2.61 |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $351.39M | -0.99 | -1.39 | -1.39 | -0.93 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $356.23M | -0.14 | -0.19 | -0.48 | -0.56 |
| Embecta Corp. (EMBC)vs › | $350.33M | 1.48 | 1.49 | 2.03 | 3.82 |
| Turn Therapeutics Inc. (TTRX)vs › | $348.22M | -0.29 | -0.18 | -0.18 | -0.18 |
| Opus Genetics, Inc. (IRD)vs › | $360.40M | N/A | -1.30 | -1.38 | -1.95 |
| Relmada Therapeutics, Inc. (RLMD)vs › | $346.45M | -0.92 | -2.05 | -3.17 | -3.94 |
Trailing EPS (TTM)
$0.36
Forward EPS (Est.)
$0.41
P/E Ratio
25.6
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.38 |
| 2024-12-31 | 0.29 |
| 2023-12-31 | 0.27 |
| 2022-12-31 | 0.15 |
| 2021-12-31 | 0.23 |
| 2020-12-31 | 0.86 |
| 2019-12-31 | 0.23 |
| 2018-12-31 | 0.25 |
| 2017-12-31 | 0.22 |
| 2016-12-31 | 0.03 |
| 2015-12-31 | 1.62 |
| 2014-12-31 | 1.58 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T19:38:35.198Z. Historical observations retain their original dates. Historical series through 2025-03-10.
